MAPT and Alzheimer disease: Given that CPECs contain a subpopulation of neural progenitor cells capable of proliferation and differentiation into various cell types, the transplantation of CPECs into the brains of AD mouse models has shown a significant reduction in brain Aβ deposition, tau phosphorylation, and reactive astrocytosis [71].